Plant Comparison
Lesser Burdock vs Common coltsfoot
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Lesser Burdock and Common coltsfoot: both belong to the Asteraceae family; they share 3 indicated uses (arthritis / joint pain, inflammation (general), skin irritation); 1 pharmacological action in common.
Evidence face-off — shared uses
| Condition | Lesser Burdock | Common coltsfoot | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 1/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 2/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The major storage carbohydrate; a prebiotic fibre.
Anti-inflammatory and antioxidant constituents.
Antimicrobial and antioxidant constituents.
Hepatotoxic constituents that are the central safety concern for this plant; regulatory limits and PA-controlled/PA-reduced products exist specifically because of these compounds.
Demulcent polysaccharide contributing to the traditional soothing action on irritated airways.
Pharmacological Actions
Traditional 'alterative' / depurative for chronic skin conditions - eczema, psoriasis, acne and boils (internally and topically)
Lesser burdock (Arctium minus) leaf, flower and root extracts (rich in arctiin/arctigenin and chlorogenic acid) are cytotoxic to breast and liver cancer cells, including multidrug-resistant tumour lines (preclinical).
Traditional & Indicated Uses
Sebaceous-gland regulator - helps balance skin oil (acne); Traditional 'alterative' / depurative for chronic skin conditions - eczema, psoriasis, acne and boils (internally and topically)
inferred from anti-inflammatory action
Arctium minus extracts show dose-dependent cytotoxicity against MCF-7 and MDA-MB-231 breast cancer and HepG2 liver cancer cells and are active against both sensitive and multidrug-resistant tumour cell lines (preclinical).
Mild diuretic supporting elimination ('detox', traditional); Traditional 'alterative' / depurative for chronic skin conditions - eczema, psoriasis, acne and boils (internally and topically)
Traditional 'alterative' / depurative for chronic skin conditions - eczema, psoriasis, acne and boils (internally and topically)
inferred from anti-inflammatory action
Traditional 'alterative' / depurative for chronic skin conditions - eczema, psoriasis, acne and boils (internally and topically)
inferred from anti-inflammatory action
inferred from diuretic action
inferred from diuretic action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from sedative action
Safety, Cautions & Contraindications
As a member of the daisy family (Asteraceae), it can cause allergic reactions in people sensitive to ragweed and related plants. The high inulin content can cause temporary bloating or gas.
May lower blood sugar (caution with antidiabetic medicines) and add to diuretics; avoid medicinal doses in pregnancy.
Safety notes (contraindications, interactions, pregnancy/lactation notes, adverse effects, dose-duration cautions) Important: Coltsfoot naturally contains pyrrolizidine alkaloids (PAs)—plant chemicals that can damage the liver and may increase cancer risk with enough exposure (EMA, 2021; Kopp et al., 2020).
Because of this, European regulators set very strict limits for PA exposure from herbal products (EMA, 2021).
Many safety-focused herbal references recommend avoiding homemade/internal coltsfoot use, unless the product is specifically made to be PA-controlled / PA-reduced (EMA, 2021).
Avoid internal use if you are pregnant or breastfeeding, have liver disease, or for children—these groups are treated as “sensitive” in PA risk guidance (EMA, 2021).
Medication caution: if you take medicines that stress the liver (some prescription drugs can), it’s extra important to avoid unregulated PA exposure (general PA risk logic; consult a clinician) (EMA, 2021).
Topical use may still carry PA considerations; EMA discusses limits and recommends use only on intact skin for PA-containing products (EMA, 2021).
Duke (2002) provides clinical support (score 2) for coltsfoot's anti-inflammatory and expectorant effects, explaining its traditional use in bronchitis and coughs. However, the plant contains hepatotoxic pyrrolizidine alkaloids (PAs), and Duke notes a carcinogenic score (1) — a critical safety concern. Commission E has placed restrictions on coltsfoot use, recommending maximum internal use of 4–6 weeks per year and avoiding use in pregnancy, lactation, and in children under 12. Duke rates its overall safety as low (+) and emphasizes that preparations free of PAs are preferred (Duke, 2002).
External Ids
Botanical Description
Biennial herb closely related to greater burdock, forming a first-year rosette of large, heart-shaped, long-stalked leaves, green above and grey-woolly beneath, generally smaller than Arctium lappa. In the second year it produces a branching flowering stem with smaller purple thistle-like flower heads in a looser, more sprawling habit, each enclosed in a globe of hooked bracts that ripen into clinging burrs.[15]
Low perennial herb notable for flowering before its leaves appear: solitary, bright yellow, dandelion-like flower heads emerge on scaly pinkish stalks in very early spring, followed later by large, hoof-shaped (heart-shaped with angular teeth), white-woolly-backed leaves arising directly from the creeping rhizome.[11]
Habitat
A common weed of waste ground, roadsides, hedgerows and disturbed soil; native to Europe and widely naturalised in North America, where it is often the most common wild burdock species.[15]
Grows on disturbed, damp or clay-rich waste ground, riverbanks, railway embankments and bare soil; native to Europe, North Africa and temperate Asia and naturalised in North America.[11]
Harvesting
The root is dug at the end of the first growing season or early in the second spring, before flowering; leaf may be gathered through the first year. Careful identification against deadly nightshade, whose root can resemble burdock, is essential before digging.[15]
Flowers are gathered in very early spring before the leaves appear; leaves are gathered later in the season once expanded. Given the plant's pyrrolizidine alkaloid content, harvesting from a positively confirmed patch (not a look-alike) and preferring PA-tested commercial material for internal use is strongly advised.[2]
Traditional Uses
Coltsfoot has an ancient European and Chinese tradition, reflected in its Latin name (tussis = cough), as an expectorant and demulcent remedy for coughs, bronchitis and irritated airways; because of its pyrrolizidine alkaloid content, contemporary use is restricted to short courses of PA-controlled preparations under regulatory limits (see contraindications).[1, 2, 12]
Preparations
Commercially prepared, pyrrolizidine-alkaloid-tested extract or syrup, the only form recommended for internal use given the plant's natural PA content.
Dried flower or leaf infused in hot water; traditional but subject to strict duration/PA-content limits under EU herbal regulation.
References
Lookalikes Review
Dangerous Lookalikes
Dosage
Not documented
EU regulatory guidance restricts internal use to PA-controlled preparations. The EMA public statement on unsaturated pyrrolizidine alkaloids records a maximum daily intake for internal use of 1 microgram of PAs for at most 6 weeks per year, or 0.1 microgram per day with no duration limit; for cutaneous use the limits are 100 micrograms for at most 6 weeks per year, or 10 micrograms without a duration limit. Not for use in pregnancy, breastfeeding, or children. Note that these are limits on PA intake, not a herb dose — no EMA monograph exists for Tussilago farfara, so there is no official posology for the herb itself. Educational reference only, not a prescription — consult a qualified practitioner and prefer tested commercial products.
References & Sources
- Ahangarpour, A., Heidari, H., Oroojan, A.A., Mirzavandi, F., Nasr Esfehani, K. and Dehghan Mohammadi, Z (2017) 'Antidiabetic, hypolipidemic and hepatoprotective effects of Arctium lappa root's hydro-alcoholic extract on nicotinamide-streptozotocin induced type 2 model of diabetes in male mice', Avicenna Journal of Phytomedicine, 7(2), pp. 169-179. Available at: https://pubmed.ncbi.nlm.nih.gov/28348972/ Preclinical
https://pubmed.ncbi.nlm.nih.gov/28348972/ - Gao, Q., Yang, M. and Zuo, Z (2018) 'Overview of the anti-inflammatory effects, pharmacokinetic properties and clinical efficacies of arctigenin and arctiin from Arctium lappa L', Acta Pharmacologica Sinica, 39(5), pp. 787-801. doi:10.1038/aps.2018.32 Traditional / reference
https://doi.org/10.1038/aps.2018.32 - Zeng, F., Li, Y., Zhang, X., Shen, L., Zhao, X. et al (2023) 'Immune regulation and inflammation inhibition of Arctium lappa L. polysaccharides by TLR4/NF-κB signaling pathway in cells', International Journal of Biological Macromolecules, 254, pp. 127700. doi:10.1016/j.ijbiomac.2023.127700 Preclinical
https://doi.org/10.1016/j.ijbiomac.2023.127700 - Fischer, S.P.M., Brusco, I., Camponogara, C., Piana, M., Faccin, H., Gobo, L.A., de Carvalho, L.M. and Oliveira, S.M (2017) 'Arctium minus crude extract presents antinociceptive effect in a mice acute gout attack model', Inflammopharmacology, 26(2), pp. 505-519. doi:10.1007/s10787-017-0384-6 Preclinical
https://doi.org/10.1007/s10787-017-0384-6 - Erdemoglu, N., Turan, N.N., Akkol, E.K., Sener, B. and Abacioglu, N (2008) 'Estimation of anti-inflammatory, antinociceptive and antioxidant activities of Arctium minus (Hill) Bernh. ssp. minus', Journal of Ethnopharmacology, 121(2), pp. 318-323. doi:10.1016/j.jep.2008.11.009 Preclinical
https://doi.org/10.1016/j.jep.2008.11.009 - Ilgun, S., Karatoprak, G.S., Polat, D.C., Safak, E.K., Yildiz, G., Kupeli Akkol, E. and Sobarzo-Sanchez, E (2022) 'Phytochemical Composition and Biological Activities of Arctium minus (Hill) Bernh.: A Potential Candidate as Antioxidant, Enzyme Inhibitor, and Cytotoxic Agent', Antioxidants, 11(10), pp. 1852. doi:10.3390/antiox11101852 Preclinical
https://doi.org/10.3390/antiox11101852 - Erol, E., Erol, K.F., Yanikoglu, R.S., Taskin, C., Kizilarslan Hancer, C. and Topcu, G (2024) 'Quantitative Determination of the Cytotoxic Compounds in Different Organs of Arctium minus (Hill) Bernh. by LC-HRESIMS Using Response Surface Methodology', ACS Omega, 9(40), pp. 41890-41903. doi:10.1021/acsomega.4c06644 Preclinical
https://doi.org/10.1021/acsomega.4c06644 - Malanik, M., Farkova, V., Krizova, J., Kresova, A., Smejkal, K., Kasparovsky, T. and Dadakova, K (2024) 'Comparison of Metabolic Profiles of Fruits of Arctium lappa, Arctium minus, and Arctium tomentosum', Plant Foods for Human Nutrition, 79(2), pp. 497-502. doi:10.1007/s11130-024-01175-w Preclinical
https://doi.org/10.1007/s11130-024-01175-w - Cimino, C.V., Colombo, M.L., Liggieri, C., Bruno, M. and Vairo-Cavalli, S (2015) 'Partial Molecular Characterization of Arctium minus Aspartylendopeptidase and Preparation of Bioactive Peptides by Whey Protein Hydrolysis', Journal of Medicinal Food, 18(8), pp. 856-864. doi:10.1089/jmf.2014.0101 Preclinical
https://doi.org/10.1089/jmf.2014.0101 - Kenny, O., Smyth, T.J., Walsh, D., Kelleher, C.T., Hewage, C.M. and Brunton, N.P (2014) 'Investigating the potential of under-utilised plants from the Asteraceae family as a source of natural antimicrobial and antioxidant extracts', Food Chemistry, 161, pp. 79-86. doi:10.1016/j.foodchem.2014.03.126 Preclinical
https://doi.org/10.1016/j.foodchem.2014.03.126 - Karadeniz, A., Alexie, G., Greten, H.J., Andersch, K. and Efferth, T (2015) 'Cytotoxicity of medicinal plants of the West-Canadian Gwich'in Native Americans towards sensitive and multidrug-resistant cancer cells', Journal of Ethnopharmacology, 168, pp. 191-200. doi:10.1016/j.jep.2015.03.052 Preclinical
https://doi.org/10.1016/j.jep.2015.03.052 - Watkins, F., Pendry, B., Sanchez-Medina, A. and Corcoran, O (2012) 'Antimicrobial assays of three native British plants used in Anglo-Saxon medicine for wound healing formulations in 10th century England', Journal of Ethnopharmacology, 144(2), pp. 408-415. doi:10.1016/j.jep.2012.09.031 Preclinical
https://doi.org/10.1016/j.jep.2012.09.031 - Abraham, E.P. and Crowfoot, D.M (1946) 'An antibacterial substance from Arctium minus and Onopordon tauricum', Nature, 158(4021), pp. 744. doi:10.1038/158744a0 Preclinical
https://doi.org/10.1038/158744a0 - Cavallito, C.J. and Kirchner, F.K (1947) 'The antibacterial principle of Arctium minus; the unsaturated lactone structure', Journal of the American Chemical Society, 69(12), pp. 3030-3032. doi:10.1021/ja01204a028 Preclinical
https://doi.org/10.1021/ja01204a028 - Herbal Reality (n.d.) 'Burdock (Arctium): Benefits, Medicinal Uses, Safety'. Available at: https://www.herbalreality.com/herb/burdock/ Traditional / reference
https://www.herbalreality.com/herb/burdock/ - Drugs.com (n.d.) 'Burdock Uses, Benefits & Dosage'. Available at: https://www.drugs.com/npp/burdock.html Traditional / reference
https://www.drugs.com/npp/burdock.html - Chan, Y.S., Cheng, L.N., Wu, J.H., Chan, E., Kwan, Y.W., Lee, S.M.Y., Leung, G.P.H., Yu, P.H.F. and Chan, S.W (2011) 'A review of the pharmacological effects of Arctium lappa (burdock)', Inflammopharmacology, 19(5), pp. 245--254. doi:10.1007/s10787-010-0062-4 Traditional / reference
https://doi.org/10.1007/s10787-010-0062-4 - Bryson, P.D. and Watanabe, A.S. and Rumack, B.H. and Murphy, R.C (1978) 'Burdock root tea poisoning. Case report involving a commercial preparation', JAMA, 239(20), pp. 2157. Available at: https://pubmed.ncbi.nlm.nih.gov/642161/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/642161/ - Berdai, M.A. and Labib, S. and Chetouani, K. and Harandou, M (2012) 'Atropa belladonna intoxication: a case report', Pan African Medical Journal, 11, pp. 72. Available at: https://pubmed.ncbi.nlm.nih.gov/22655106/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/22655106/ - Oerlemans, C. and de Vries, I. and van Riel, A.J.H.P (2017) 'Anticholinergic syndrome caused by contaminated herbal tea; acting swiftly to identify the source', Nederlands Tijdschrift voor Geneeskunde, 161, pp. D1261. Available at: https://pubmed.ncbi.nlm.nih.gov/28612694/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/28612694/
- Ahmad, I., Kudaibergenova, B., Ahmad, M. and others (2025) 'Coltsfoot (Tussilago farfara L.; Asteraceae): modern methods of extraction, phytochemistry, nanoparticles synthesis, ethnopharmacology, and biological activities', Natural Product Research, pp. 1-20. doi:10.1080/14786419.2025.2548616 Traditional / reference
https://doi.org/10.1080/14786419.2025.2548616 - Chen, S., Dong, L., Quan, H., Zhou, X. and others (2020) 'A review of the ethnobotanical value, phytochemistry, pharmacology, toxicity and quality control of Tussilago farfara L. (coltsfoot)', Journal of Ethnopharmacology, 267, pp. 113478. doi:10.1016/j.jep.2020.113478 Traditional / reference
https://doi.org/10.1016/j.jep.2020.113478 - Feng, J., Zhang, Y., Qin, X., Gao, T. and others (2022) 'Novel Quinic Acid Glycerates from Tussilago farfara Inhibit Polypeptide GalNAc-Transferase', ChemBioChem, 23(3), pp. e202100539. doi:10.1002/cbic.202100539 Preclinical
https://doi.org/10.1002/cbic.202100539 - Zhao, J., Evangelopoulos, D., Bhakta, S., Gray, A.I. and Seidel, V (2014) 'Antitubercular activity of Arctium lappa and Tussilago farfara extracts and constituents', Journal of Ethnopharmacology, 155(1), pp. 796-800. doi:10.1016/j.jep.2014.06.034 Preclinical
https://doi.org/10.1016/j.jep.2014.06.034 - Avila, C., Breakspear, I., Hawrelak, J., Salmond, S. and Evans, S (2020) 'A systematic review and quality assessment of case reports of adverse events for borage (Borago officinalis), coltsfoot (Tussilago farfara) and comfrey (Symphytum officinale)', Fitoterapia, 142, pp. 104519. doi:10.1016/j.fitote.2020.104519 Meta-analysis / review
https://doi.org/10.1016/j.fitote.2020.104519 - Lee, J., Park, S., Kim, M.J., Kwon, S.J. and others (2019) 'Sesquiterpenoids from Tussilago farfara Flower Bud Extract for the Eco-Friendly Synthesis of Silver and Gold Nanoparticles Possessing Antibacterial and Anticancer Activities', Nanomaterials (Basel), 9(6), pp. 819. doi:10.3390/nano9060819 Preclinical
https://doi.org/10.3390/nano9060819 - Bota, V.B., Neamtu, A.A., Olah, N.K., Chiselita, O. and others (2022) 'A Comparative Analysis of the Anatomy, Phenolic Profile, and Antioxidant Capacity of Tussilago farfara L. Vegetative Organs', Plants (Basel), 11(13), pp. 1663. doi:10.3390/plants11131663 Preclinical
https://doi.org/10.3390/plants11131663 - Boucher, M.A., Cote, H., Pichette, A., Ripoll, L. and Legault, J (2020) 'Chemical composition and antibacterial activity of Tussilago farfara (L.) essential oil from Quebec, Canada', Natural Product Research, 34(4), pp. 545-548. doi:10.1080/14786419.2018.1489384 Preclinical
https://doi.org/10.1080/14786419.2018.1489384 - Li, Z.Y., Zhang, J., Zhang, Y.B., Yang, X.W. and others (2022) 'Polyhydroxylated eudesmane sesquiterpenoids and sesquiterpenoid glucoside from the flower buds of Tussilago farfara', Chinese Journal of Natural Medicines, 20(4), pp. 301-308. doi:10.1016/S1875-5364(21)60120-6 Preclinical
https://doi.org/10.1016/S1875-5364(21)60120-6 - Jang, H., Lee, J.W., Lee, C., Jin, Q. and others (2016) 'Sesquiterpenoids from Tussilago farfara inhibit LPS-induced nitric oxide production in macrophage RAW 264.7 cells', Archives of Pharmacal Research, 39(1), pp. 127-132. doi:10.1007/s12272-015-0667-7 Preclinical
https://doi.org/10.1007/s12272-015-0667-7 - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Westendorf, J., Czok, G., Marquardt, R., Nausner, M., Krauer, B. and Paul, H.L (1988) 'Pyrrolizidine alkaloid content of Tussilago farfara plants from different regions and preparations', pp. 903--909. Traditional / reference
https://scholar.google.com/scholar?q=Pyrrolizidine%20alkaloid%20content%20of%20Tussilago%20farfara%20plants%20from%20different%20regions%20and%20preparations - European Medicines Agency (HMPC) (2021) 'Public statement on the use of herbal medicinal products containing toxic, unsaturated pyrrolizidine alkaloids (PAs), including recommendations regarding contamination of herbal medicinal products with PAs, Revision 1'. Available at: https://www.ema.europa.eu/en/documents/public-statement/public-statement-use-herbal-medicinal-products-containing-toxic-unsaturated-pyrrolizidine-alkaloids-pas-including-recommendations-regarding-contamination-herbal-medicinal-products-pyrrolizidine_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/public-statement/public-statement-use-herbal-medicinal-products-containing-toxic-unsaturated-pyrrolizidine-alkaloids-pas-including-recommendations-regarding-contamination-herbal-medicinal-products-pyrrolizidine_en.pdf - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Sperl, W. and Stuppner, H. and Gassner, I. and Judmaier, W. and Dietze, O. and Vogel, W (1995) 'Reversible hepatic veno-occlusive disease in an infant after consumption of pyrrolizidine-containing herbal tea', European Journal of Pediatrics, 154(2), pp. 112-6. doi:10.1007/BF01991912 Clinical study
https://doi.org/10.1007/BF01991912
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.